Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
150 participants
INTERVENTIONAL
2021-02-08
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Ophthalmic Antiseptic Preparations
NCT05974124
Povidone-iodine Antisepsis for Strabismus Surgery
NCT00461656
Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora
NCT01739920
Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery
NCT00491049
Effect of Four Different Diagnostic Eye Drops on Tear Film Thickness
NCT07230548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Povidone-Iodine 0.3 %
A tampon is soaked in diluted PI 0.3% and placed on the inside of the lower eyelid of one eye, where it will release iodine molecules for 20 minutes before being removed.
Povidone-Iodine 0.3%
Low concentration iodine
Povidone-Iodine 5 %
Eye drops of 5% PI is the standard disinfection before eye surgery. The drops will be dripped in one eye and allowed to work for 2 minutes.
Povidone-Iodine 5%
Standard concentration iodine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Povidone-Iodine 0.3%
Low concentration iodine
Povidone-Iodine 5%
Standard concentration iodine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients competent to give written consent
Exclusion Criteria
* Known epitheliopathy
* Contact lens wear
* Use of prescription ophthalmic medications
* Diabetes
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorunn Helbostad, MD PhD
Role: STUDY_DIRECTOR
Norwegian University of Science and Technology
Marit Fagerli, MD
Role: STUDY_DIRECTOR
Clinic of Ear-Nose-Throat, Eye and Maxillofacial Surgery, St. Olavs Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Olavs Hospital
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-001179-35
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
SW2019-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.